Product Liability
Jun. 30, 2010
Drug Recalls May Prompt Suits
A series of recent recalls of tainted medicines has ignited the ire of Congress members, who want to increase the U.S. Food and Drug Administration's authority over drug manufacturing.
Daily Journal Staff Writer
A series of recent recalls of defective medicines has raised the ire of Congress, which wants to increase the U.S. Food and Drug Administration's authority over drug manufacturing.
Whether the spate of recalls will spawn the relatively rare pharmaceutical manufacturing defect lawsuits remains to be seen, according to lawyers who advise pharmaceutical and medical device companies. ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In